Dimitris Polygenis's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Dimitris Polygenis
President
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
15
Since Nov 2021
15
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Raquel Dancho · Member of Parliament
Health Canada, with respect to the role of wholesalers in the management of drug shortages
Read more
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Rechie Valdez · Member of Parliament
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Read more
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Official report
Aaron Wudrick · Director of Policy, House of Commons
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Read more
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Official report
Ali Ehsaasi · MP Willowdale, House of Commons
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Anthony Laporte · Strategic Advisor, Implementation and Delivery, Prime Minister's Office (PMO)
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Elizabeth Wong · Sr Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Jade Mallette · Chief of Staff, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Read more
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Official report
Paul Morin · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Read more
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Official report
Pamela Aung-Thin · ADM, HPFB, Health Canada (HC)
Policies and programs aimed at red tape reduction to reduce regulatory burdens and timelines in the pharmaceutical distribution and associated sectors
Official report
Maggie Chi · MP Don Valley North
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Rechie Valdez · Member of Parliament
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
Maninder Sidhu · Minister of International Trade, Global Affairs Canada (GAC)
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Official report
Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs
Read more
Health Canada, with respect to the regulation and funding of wholesale distribution of pharmaceuticals and regulation of pharmacy activities
Official report
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.